GLP-1 RAs Show Greater HbA1c Improvement vs DPP-4 Inhibitors Tags DPP-4 inhibitors GLP-1 agonists hBA1c Read more about GLP-1 RAs Show Greater HbA1c Improvement vs DPP-4 Inhibitors
MACE, Hypoglycemia Risks Differ Among Sulfonylureas Tags Coronary artery disease Hypoglycemia Sulphonylureas Read more about MACE, Hypoglycemia Risks Differ Among Sulfonylureas
Higher HbA1c Variability Linked to Mortality Risk in T2DM Tags Diabetic Nephropathy Diabetic Neuropathy Myocardial infarction hBA1c Read more about Higher HbA1c Variability Linked to Mortality Risk in T2DM
Dose Escalation Linked to GI Tolerance With Incretins Tags GLP-1 agonists Read more about Dose Escalation Linked to GI Tolerance With Incretins
Fitness Levels Align With Key Metabolic Proteins After GDM Tags Coronary artery disease Stroke Coronary artery disease Myocardial infarction Stroke Read more about Fitness Levels Align With Key Metabolic Proteins After GDM
Circulating Fatty Acids Show Divergent GDM Associations Tags Caeserian Section Hyperbilurubinemia Macrosomia (HBW) Premature birth Read more about Circulating Fatty Acids Show Divergent GDM Associations
Canagliflozin Reduces Myocardial Fibrosis on CMR in T2DM Tags MRI Chest Myocardial infarction hBA1c SGLT-2 Inhibitor Read more about Canagliflozin Reduces Myocardial Fibrosis on CMR in T2DM
AI-Based Tool Estimates Exercise Hypoglycemia Risk in T1DM Tags Hypoglycemia Read more about AI-Based Tool Estimates Exercise Hypoglycemia Risk in T1DM
COVID-19 Infection Accompanied by Insulin Resistance Tags Hypoglycemia Immunocompromise Read more about COVID-19 Infection Accompanied by Insulin Resistance
GLP-1RAs Rarely Used as Early Therapy in T2DM Tags GLP-1 agonists SGLT-2 Inhibitor Read more about GLP-1RAs Rarely Used as Early Therapy in T2DM
